Mucus and gynolactose might control host-
Bifidobacterium interactions. Their respective roles were investigated in this study using gnotobiotic mice. By comparing glycoprotein SDS-PAGE profiles, mucus from various murine lines (NC, CF
1, BALB/c and C
3H) were differentiated. We attempted then to determine the intestinal substrates utilized by various bifidobacteria. First, NC and CF
1 germfree mice received an inoculum of a murine species,
B. animalis. Bacteria utilized the glycosyl fraction of several CF
1. glycocompounds. No such extensive degradation was observed in NC mice. In constrast, both NC and CF
1, mice responded to colonization by modifying hexosamine composition of their high molecular weight mucins. Three human species (
B. bifidum, B. breve and
B. longum) were then assayed for their
in vivo capacity to degrade murine mucus from C3H mice.
B. bifidum utilized extensively glycoproteins from the mucus, whereas
B. longum and
B. breve were unable to degrade them. However, none of the human strains led to intestinal mucins modification. Origin of the strains seemed to be a factor controlling the host response. Finally, gynolactose effect was investigated in germfree,
B. breve-associated, and infant flora-associated C
3H mice. Few modifications to mucus composition were noticed in the first two cases. In infant floraassociated mice, new intestinal glycoproteins and proteins were detected but bacterial counts were not changed. Host response to gynolactose might depend on the implantation of some unknown intestinal bacteria. It is likely that the proliferation of bifidobacteria shown in breast-fed infants does not correspond to a direct gynolactose promoting effect. But it is probably related to mucus modification induced by gynolactose.
View full abstract